Ionis Pharmaceuticals (IONS) Other Working Capital Changes (2013 - 2026)

Ionis Pharmaceuticals' Other Working Capital Changes history runs 10 years deep, the most recent figure standing at -$20.8 million for Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 51.76% year-over-year to -$20.8 million in Q1 2026; TTM through Mar 2026 was -$76.8 million, a 37.9% increase from a year earlier, with the FY2025 full-year figure at -$69.7 million, up 55.53% from the prior year.
• Other Working Capital Changes declined to -$20.8 million in Q1 2026 per IONS's latest filing, from -$19.1 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $101.0 million in Q3 2025 and bottomed at -$90.3 million in Q4 2025.
• The 5-year median for Other Working Capital Changes is $7.4 million (2026), against an average of $7.5 million.
• Across the five-year window, Other Working Capital Changes soared 817.28% in 2023 and slumped 327.94% in 2024, its largest moves.
• Year by year, Other Working Capital Changes stood at -$15.8 million in 2022, then plunged by 290.49% to -$61.8 million in 2023, then jumped by 76.85% to -$14.3 million in 2024, then tumbled by 33.77% to -$19.1 million in 2025, then fell by 8.82% to -$20.8 million in 2026.
• Per Business Quant, the three latest IONS Other Working Capital Changes figures stand at -$20.8 million (Q1 2026), -$19.1 million (Q4 2025), and -$16.1 million (Q3 2025).